A previous study showed that elevation of serum GGT is associated with hepatic steatosis [31], which contributes to development of insulin resistance by altering the secretion of factors from the liver such as lipids and hepatokines including retinol-binding protein 4 and fetuin A and B [31–34]. Here, RBP4 is linked to fatty liver disease.